These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2124297)

  • 1. Valproate-induced hepatoxicity: protective effect of L-carnitine supplementation.
    Sugimoto T; Nishida N; Murakami K; Woo M; Sakane Y; Yasuhara A; Shuto H; Hatanaka T; Kobayashi Y
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):387-8. PubMed ID: 2124297
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproate toxicity: risk-screening strategies.
    Willmore LJ; Triggs WJ; Pellock JM
    J Child Neurol; 1991 Jan; 6(1):3-6. PubMed ID: 2002198
    [No Abstract]   [Full Text] [Related]  

  • 3. Carnitine, valproate, and toxicity.
    Coulter DL
    J Child Neurol; 1991 Jan; 6(1):7-14. PubMed ID: 2002205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    DeVivo DC
    Neurology; 2002 Feb; 58(3):507-8. PubMed ID: 11839873
    [No Abstract]   [Full Text] [Related]  

  • 5. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-carnitine supplementation in childhood epilepsy: current perspectives.
    De Vivo DC; Bohan TP; Coulter DL; Dreifuss FE; Greenwood RS; Nordli DR; Shields WD; Stafstrom CE; Tein I
    Epilepsia; 1998 Nov; 39(11):1216-25. PubMed ID: 9821988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
    Bøhmer T; Bøen A; Høymork SC
    Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.
    Felker D; Lynn A; Wang S; Johnson DE
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):211-8. PubMed ID: 24450420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-carnitine supplementation as a potential therapy for suspected hyperammonaemic encephalopathy.
    Khakwani A; Gannon D
    J R Coll Physicians Edinb; 2019 Dec; 49(4):301-303. PubMed ID: 31808457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    Bohan TP; Helton E; McDonald I; König S; Gazitt S; Sugimoto T; Scheffner D; Cusmano L; Li S; Koch G
    Neurology; 2001 May; 56(10):1405-9. PubMed ID: 11376200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of carnitine supplementation during valproic acid therapy.
    Raskind JY; El-Chaar GM
    Ann Pharmacother; 2000 May; 34(5):630-8. PubMed ID: 10852092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenetic basis of pharmaceutical hepatitis induced by depakine in children].
    Podymova SD; Sadovnikova IV
    Eksp Klin Gastroenterol; 2009; (8):30-5. PubMed ID: 20469676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carnitine supplementation in valproate-induced hyperammonaemia.
    Böhles H; Sewell AC; Wenzel D
    Acta Paediatr; 1996 Apr; 85(4):446-9. PubMed ID: 8740302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium valproate -- induced skeletal myopathy.
    Kasturi L; Sawant SP
    Indian J Pediatr; 2005 Mar; 72(3):243-4. PubMed ID: 15812121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.
    Qiliang L; Wenqi S; Hong J
    Indian Pediatr; 2018 Mar; 55(3):222-224. PubMed ID: 29629695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rapid change to monotherapy with valproic acid in children.
    Hurst DL
    J Child Neurol; 1993 Oct; 8(4):357-9. PubMed ID: 8228032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy.
    Steinborn B; Galas-Zgorzalewicz B
    Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Valproate dosage].
    Meyer FP; Walther H
    Psychiatr Neurol Med Psychol (Leipz); 1989 Mar; 41(3):134-43. PubMed ID: 2498918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.